Association of FSHR gene polymorphisms with endometriosis in women visiting tertiary-care hospitals of Lahore, Pakistan

article OA: gold CC0 ⤵ 2 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-08

Follicle stimulating hormone receptor gene polymorphisms rs6166 and rs6165, specifically haplotype AA, were found to be associated with an increased risk of endometriosis in Pakistani women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

This 2013–2016 case-control study from tertiary-care hospitals in Lahore, Pakistan examined whether follicle-stimulating hormone receptor (FSHR) gene single nucleotide polymorphisms rs6166 (Asn680Ser) and rs6165 (Ala307Thr) are associated with endometriosis risk. DNA from whole blood leukocytes was sequenced (at Yale University, USA) for 156 women diagnosed with stage II–IV endometriosis with infertility and 208 randomly recruited controls, excluding women with adenomyosis, ovarian cancer, and leiomyoma; the paper pools cases by stage and fertility status. The authors report higher frequencies of the rs6166 “A” allele (Asn/Asn) and the rs6165 “A” allele (Thr/Thr) in endometriosis versus controls, with corresponding increased odds ratios, and they also find different haplotype distributions including a lower frequency of the GG haplotype in endometriosis than controls. This paper is centrally about endometriosis—linking FSHR rs6166/rs6165 polymorphisms and haplotypes to endometriosis in Pakistani women.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

OBJECTIVE: The study aimed to explore the association of endometriosis risk factors with single nucleotide polymorphisms rs6166 and rs6165 (Asn680Ser and Ala307Thr) of follicle stimulating hormone receptor (FSHR) gene in Pakistani women. METHODS: This study was conducted from 2013 to 2016. The sampling and extraction of DNA was done in Department of Zoology GC University, Lahore, while the sequencing was performed at Yale University, USA. This case control study consisted of 364 subjects including 156 women diagnosed with endometriosis and 208 conveniently recruited controls. Subjects diagnosed at stage II-IV endometriosis with infertility were pooled for study. The women with adenomyosis, ovarian cancer and leiomyoma were excluded. The whole blood leukocytes were used for DNA extraction. Two important polymorphisms of exon 10 of FSHR gene were analyzed by direct DNA sequencing both in endometriosis and controls. RESULTS: Genetic variant SNP rs6166 in the affected endometriosis subjects exhibited high incidence of allele "A" (Asn/Asn) 68.3% as compared to controls 33.7% (OR= 4.240; P =0.001). Similarly, the allele "A" of SNP rs6165 (Thr/Thr) was more frequent in endometriosis 67.3% than in control subjects 37.5% (OR =3.430, P =0.001). The occurrence of haplotype AA (Asn/Thr) was 45.5% in endometriosis and 11 % in control subjects (P= 0.001). Remarkably, the incidence of haplotype GG (Ser/Ala) was contrary to previous observations, since only 9.9% occurred in endometriosis as opposed to 45.2% in controls (P= 0.001). CONCLUSIONS: Investigation of FSHR gene polymorphisms rs6165and rs6166 (Ala307Thr and Asn680Ser) in the current study showed that haplotype AA (680Asn/307Thr) was associated with endometriosis in Pakistani women.
Full text 1,702 characters · extracted from oa-html · 3 sections · click to expand

Objectives

The study was aimed to explore the association of endometriosis risk factors with single nucleotide polymorphisms rs6166 and rs6165 (Asn680Ser and Ala307Thr) of follicle stimulating hormone receptor (FSHR) gene in Pakistani women.

Methods

This study was conducted from 2013 to 2016. The sampling and extraction of DNA was done in Department of Zoology GC University Lahore while the sequencing was performed at Yale University USA. This case control study consists of 364 subjects including 156 women diagnosed with endometriosis and 208 randomly recruited controls. Subjects diagnosed at stage II-IV endometriosis with infertility were pooled for study. The women with adenomyosis, ovarian cancer and leiomyoma were excluded. The whole blood leukocytes were used for DNA extraction. Two important polymorphisms of exon 10 of FSHR gene were analyzed by direct DNA sequencing both in endometriosis and controls.

Results

SNP rs6166 in the affected endometriosis subjects exhibited high incidence of allele “A” (Asn/Asn) 68.3% as compared to controls 33.7% (OR= 4.240; P =0.001). Similarly, the allele “A” of SNP rs6165 (Thr/Thr) was more frequent in endometriosis 67.3% than in control subjects 37.5% (OR =3.430, P =0.001). The occurrence of haplotype AA (Asn/Thr) was 45.5% in endometriosis and 11 % in control subjects (P= 0.001). Remarkably, the incidence of haplotype GG (Ser/Ala) was contrary to previous observations, since only 9.9% occurred in endometriosis as opposed to 45.2% in controls (P= 0.001). Continuous...

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisadenomyosisinfertility

MeSH descriptors

Endometriosis Endometriosis Endometriosis Receptors, FSH Receptors, FSH Case-Control Studies Female Genotype Humans Pakistan Pakistan Polymorphism, Single Nucleotide Tertiary Care Centers

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

europepmc
last seen: 2026-06-16T06:07:01.518242+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:24:31.988741+00:00
License: CC0 · commercial use OK